We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Papaya Leaf Extract Slows Growth of Cancer Cell Cultures

By LabMedica International staff writers
Posted on 23 Mar 2010
Print article
Cancer researchers have found that a water extract prepared from dried papaya leaves has potent anticancer properties when tested on cultures of cells taken from more than 10 different types of tumors.

Investigators at the University of Florida (Gainesville, FL, USA) and the University of Tokyo (Japan) sought to bring scientific order to folk anecdotes on the anticancer properties of papayas. Their plan was to examine the effect of an aqueous-extracted papaya leaf fraction on the growth of various tumor cell lines and on the antitumor effect of human lymphocytes. In addition, they attempted to identify the functional molecular weight fraction in the papaya leaf extract. In this study the effect of papaya leaf extract on the proliferative responses of tumor cell lines and human peripheral blood mononuclear cells (PBMC), and cytotoxic activities of PBMC were assessed by the incorporation of radioactive thymidine. Flow cytometric analysis and measurement of caspase-3/7 activities were performed to confirm the induction of apoptosis on tumor cells. Cytokine productions by PBMC were measured by ELISA. Gene profiling of the effect of leaf extract treatment was performed by microarray analysis and real-time RT-PCR.

Results published in the February 17, 2010, issue of the Journal of Ethnopharmacology revealed that papaya leaf extract showed significant growth inhibitory activity on cervix, breast, liver, lung, and pancreas tumor-cell lines. In PBMCs, the production of interleukin-2 (IL-2) and IL-4 was reduced following the addition of leaf extract, whereas that of IL-12p40, IL-12p70, IFN-gamma (interferon-gamma) and TNF-alpha (tumor necrotic factor-alpha) was enhanced without growth inhibition. In addition, cytotoxicity of activated PBMCs was enhanced by the addition of the extract. Moreover, microarray analyses showed that the expression of 23 immunomodulatory genes, classified by gene ontology analysis, was enhanced by the addition of papaya leaf extract.

The investigators identified the active component of the papaya leaf extract, which inhibited tumor cell growth and stimulated anti-tumor effects, to be a fraction with molecular weight less than 1,000. Importantly, the papaya extract did not have any toxic effects on normal cells.

"Based on what I have seen and heard in a clinical setting, nobody who takes this extract experiences demonstrable toxicity; it seems like you could take it for a long time — as long as it is effective,” said contributing author Dr. Nam Dang, professor of hematology and oncology at the University of Florida.

Related Links:
University of Florida
University of Tokyo


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.